144 related articles for article (PubMed ID: 27778231)
1. Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia.
Dehghan-Nayeri N; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A; Goudarzi Pour K; Eshghi P
J Cell Commun Signal; 2017 Jun; 11(2):137-145. PubMed ID: 27778231
[TBL] [Abstract][Full Text] [Related]
2. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
[TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL).
Jiang N; Kham SK; Koh GS; Suang Lim JY; Ariffin H; Chew FT; Yeoh AE
J Proteomics; 2011 May; 74(6):843-57. PubMed ID: 21396490
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of serum autoantibodies in children with B-cell acute lymphoblastic leukemia by serological proteome analysis.
Yu R; Yang S; Liu Y; Zhu Z
Proteome Sci; 2022 Feb; 20(1):3. PubMed ID: 35109855
[TBL] [Abstract][Full Text] [Related]
5. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of childhood leukemia.
Hegedus CM; Gunn L; Skibola CF; Zhang L; Shiao R; Fu S; Dalmasso EA; Metayer C; Dahl GV; Buffler PA; Smith MT
Leukemia; 2005 Oct; 19(10):1713-8. PubMed ID: 16136170
[TBL] [Abstract][Full Text] [Related]
9. A Single Talent Immunogenic Membrane Antigen and Novel Prognostic Predictor: voltage-dependent anion channel 1 (VDAC1) in Pancreatic Cancer.
Wang W; Zhang T; Zhao W; Xu L; Yang Y; Liao Q; Zhao Y
Sci Rep; 2016 Sep; 6():33648. PubMed ID: 27659305
[TBL] [Abstract][Full Text] [Related]
10. No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
Igarashi S; Manabe A; Ohara A; Kumagai M; Saito T; Okimoto Y; Kamijo T; Isoyama K; Kajiwara M; Sotomatsu M; Sugita K; Sugita K; Maeda M; Yabe H; Kinoshita A; Kaneko T; Hayashi Y; Ikuta K; Hanada R; Tsuchida M
J Clin Oncol; 2005 Sep; 23(27):6489-98. PubMed ID: 16170158
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
12. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
Pouyanrad S; Rahgozar S; Ghodousi ES
Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
[TBL] [Abstract][Full Text] [Related]
14. The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia.
Geldenhuys WJ; Nair RR; Piktel D; Martin KH; Gibson LF
J Pharmacol Exp Ther; 2019 Jul; 370(1):25-34. PubMed ID: 31010844
[TBL] [Abstract][Full Text] [Related]
15. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
[TBL] [Abstract][Full Text] [Related]
16. [Effect of glucocorticoid on the expression of Puma in acute lymphoblastic leukemia].
Xu B; Wang BJ; Li AM; Lock R
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):151-4. PubMed ID: 16613713
[TBL] [Abstract][Full Text] [Related]
17. PLK1 expression and BI 2536 effects in childhood acute lymphoblastic leukemia.
Oliveira JC; Pezuk JA; Brassesco MS; Morales AG; Queiroz RG; Scrideli CA; Tone LG
Pediatr Blood Cancer; 2014 Jul; 61(7):1227-31. PubMed ID: 24519995
[TBL] [Abstract][Full Text] [Related]
18. CoQ
Hseu YC; Thiyagarajan V; Ou TT; Yang HL
Arch Toxicol; 2018 Jan; 92(1):301-322. PubMed ID: 28918503
[TBL] [Abstract][Full Text] [Related]
19. BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia.
Jiang N; Koh GS; Lim JY; Kham SK; Ariffin H; Chew FT; Yeoh AE
Exp Hematol; 2011 Mar; 39(3):321-9, 329.e1-3. PubMed ID: 21130142
[TBL] [Abstract][Full Text] [Related]
20. VDAC1 is regulated by BRD4 and contributes to JQ1 resistance in breast cancer.
Yang G; Zhou D; Li J; Wang W; Zhong W; Fan W; Yu M; Cheng H
Oncol Lett; 2019 Sep; 18(3):2340-2347. PubMed ID: 31452730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
